Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital Sydney Street, London, United Kingdom (Z.K., P.F.F., A.D.S., S.N.-V., D.N.F., D.J.P.).
National Heart and Lung Institute, Imperial College, London, United Kingdom (Z.K., P.F.F., A.D.S., S.N.-V., D.N.F., D.J.P.).
Circ Cardiovasc Imaging. 2020 May;13(5):e009901. doi: 10.1161/CIRCIMAGING.119.009901. Epub 2020 May 15.
Background Cardiac amyloidosis (CA) is a disease of interstitial myocardial infiltration, usually by light chains or transthyretin. We used diffusion tensor cardiovascular magnetic resonance (DT-CMR) to noninvasively assess the effects of amyloid infiltration on the cardiac microstructure. Methods DT-CMR was performed at diastole and systole in 20 CA, 11 hypertrophic cardiomyopathy, and 10 control subjects with calculation of mean diffusivity, fractional anisotropy, and sheetlet orientation (secondary eigenvector angle). Results Mean diffusivity was elevated and fractional anisotropy reduced in CA compared with both controls and hypertrophic cardiomyopathy (<0.001). In CA, mean diffusivity was correlated with extracellular volume (=0.68, =0.004), and fractional anisotropy was inversely correlated with circumferential strain (=-0.65, =0.02). In CA, diastolic secondary eigenvector angle was elevated, and secondary eigenvector angle mobility was reduced compared with controls (both <0.001). Diastolic secondary eigenvector angle was correlated with amyloid burden measured by extracellular volume in transthyretin, but not light chain amyloidosis. Conclusions DT-CMR can characterize the microstructural effects of amyloid infiltration and is a contrast-free method to identify the location and extent of the expanded disorganized myocardium. The diffusion biomarkers mean diffusivity and fractional anisotropy effectively discriminate CA from hypertrophic cardiomyopathy. DT-CMR demonstrated that failure of sheetlet relaxation in diastole correlated with extracellular volume in transthyretin, but not light chain amyloidosis. This indicates that different mechanisms may be responsible for impaired contractility in CA, with an amyloid burden effect in transthyretin, but an idiosyncratic effect in light chain amyloidosis. Consequently, DT-CMR offers a contrast-free tool to identify novel pathophysiology, improve diagnostics, and monitor disease through noninvasive microstructural assessment.
心脏淀粉样变性(CA)是一种间质心肌浸润性疾病,通常由轻链或转甲状腺素蛋白引起。我们使用弥散张量心血管磁共振(DT-CMR)技术无创性评估淀粉样浸润对心脏微观结构的影响。
在 20 例 CA、11 例肥厚型心肌病和 10 例对照者中分别于舒张期和收缩期进行 DT-CMR,计算平均弥散度、各向异性分数和薄片定向(次特征向量角)。
与对照组和肥厚型心肌病相比,CA 的平均弥散度升高,各向异性分数降低(均<0.001)。在 CA 中,平均弥散度与细胞外容积呈正相关(r=0.68,P=0.004),各向异性分数与周向应变呈负相关(r=-0.65,P=0.02)。在 CA 中,舒张期次特征向量角升高,次特征向量角移动度降低,与对照组相比差异均有统计学意义(均<0.001)。舒张期次特征向量角与转甲状腺素淀粉样变的细胞外容积所测淀粉样负荷相关,但与轻链淀粉样变无关。
DT-CMR 可描述淀粉样浸润的微观结构影响,是一种无对比剂的方法,可识别扩张、紊乱心肌的位置和范围。扩散生物标志物平均弥散度和各向异性分数可有效区分 CA 和肥厚型心肌病。DT-CMR 显示舒张期薄片松弛失败与转甲状腺素淀粉样变的细胞外容积相关,与轻链淀粉样变无关。这表明不同的机制可能导致 CA 心肌收缩功能障碍,转甲状腺素淀粉样变与淀粉样负荷相关,而轻链淀粉样变则与独特的机制相关。因此,DT-CMR 为识别新的病理生理学、改善诊断和通过无创性微观结构评估监测疾病提供了一种无对比剂的工具。